BNET Industries
Last Fiscal Year Sales:$22.0M
- Private
- US
Dow Jones Description
In 2006, Ambion was acquired by Applied Biosystems, a technology leader and driving force in the changing dynamics of the life science marketplace for over 25 years. Ambion is now a center of excellence within the Applied Biosystems consumables business. The Ambion brand encompasses a complete range of products for researchers whose work involves RNA. These include products for the isolation, detection, quantification, amplification, and characterization of RNA.
General Manager of Ambion Diagnostics
Jeff WilliamsNumber of Employees 225
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
News & Analysis
Filter by
ambion inc. - All News and Analysis
Ambion, an Applied Biosystems company
- 2008-08-15
Ambion, an Applied Biosystems company, introduced the Ambion MagMAX Express and Express-96 Magnetic Particle Processors.
Ambion's big day paves way for Salesian
- 2007-11-04
RICHMOND -- When Salesian High sophomore Andrew Ambion wake up Saturday, it's highly unlikely he figured he would be making a lasting memory in the afternoon's Bay Football League game against Sacred Heart Prep-Atherton. Ambion's big moment came to start the second half. His 79-yard kickoff return...
Ambion's Former CEO and Founder Launches Asuragen
- 2006-03-14
AUSTIN, Texas -- The completion of the $273M sale of Ambion's Research Products Division to Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, resulted in the simultaneous spin-off of Asuragen, Inc. Asuragen is a newly formed molecular diagnostic company led by Matt Winkler, founder and former CEO of Ambion, Inc....
Applied Biosystems Completes Acquisition of the Research Products Division of Ambion, Inc
- 2006-03-02
FOSTER CITY, Calif. & AUSTIN, Texas -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, announced today that it has completed the previously announced acquisition of the Research Products Division of Ambion, Inc., a premium provider of innovative products for the study and analysis of ribonucleic acid RNA, the central...
New Advancements from Ambion Services in Data Analysis for MicroRNA Profiling
- 2006-02-17
AUSTIN, Texas -- Ambion Services announces the release of a new expression profiling service specifically for microRNA analysis that surpasses any other offering currently in the market. A growing body of evidence suggests that microRNAs could be useful in diagnosis and treatment for a range of diseases. E[acute accent]Based on...
Under a license and supply agreement, GE Healthcare will manufacture for Ambion microRNA microarrays
- 2006-01-31
Under a license and supply agreement, GE Healthcare will manufacture for Ambion microRNA microarrays utilizing its CodeLink Bioarray technology.
Applied Biosystems acquires RNA reagent supplier Ambion
- 2005-12-31
Foster City, CA and Austin, TX 12/27/05-Applied Biosystems has signed a definitive agreement to acquire Ambion's Research Products Division, a supplier of RNA-based reagents, for $273 million in cash. Ambion's Research Products Division sells sample preparation, RNAi, micro RNA, and gene expression and array products. Ambion's 2005 revenues are forecasted...
Applied Biosystems to Acquire the Research Products Division of Ambion, Inc., a Premium Provider of Innovative RNA-Based Consumables
- 2005-12-27
FOSTER CITY, Calif. & AUSTIN, Texas -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, and Ambion, Inc. today announced they have signed a definitive agreement whereby Applied Biosystems will acquire the Research Products Division of Ambion, a premium supplier of RNA-based reagents for life science research and drug development,...
Ambion Provides Additional Human Genome-Wide siRNA Libraries
- 2005-12-19
AUSTIN, Texas -- Ambion, Inc. today announced that the Max Planck Institute for Molecular Cell Biology and Genetics (MPI-CBG) in Dresden, Germany has received final shipment of Ambion's Genome-Wide Human siRNA Library for its research needs. In July of this year, Marino Zerial, Director of the MPI-CBG, and colleagues published...
Ambion launched the Silencer CellReady siRNA Libraries in a pre-plated
- 2005-12-15
Ambion launched the Silencer CellReady siRNA Libraries in a pre-plated, ready-to-transfect 96-well format, designed in collaboration with Cenix BioScience.
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Jeff Williams | General Manager of Ambion Diagnostics |
| Matt Winkler | Founder |
| Mark Macera | Nucleic Acids Senior Production Manager |
| Gary Dewbre | Tissue Procurement Administrator |
| Richard Fekete | Research Scientist |
| Organization | Position | Status |
|---|---|---|
| Ambion Inc. | General Manager of Ambion Diagnostics | Current |
| Organization | Position | Status |
|---|---|---|
| Asuragen, Inc | CEO,Cso | Current |
| Ambion Inc. | Founder | Current |
| Asuragen, Inc | Founder | Current |
| Ambion Inc. | President & CEO | Former |
| The University of Texas at Austin | Associate Professor | Former |
| University of California, Berkeley | Ph.D. In Zoology | Former |
| University of California, Berkeley | B.S. Degree In Genetics | Former |
| Organization | Position | Status |
|---|---|---|
| Ambion Inc. | Nucleic Acids Senior Production Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Ambion Inc. | Tissue Procurement Administrator | Current |
| Organization | Position | Status |
|---|---|---|
| Applied Biosystems Group | Manager, Scientists, Sample Preparation R&D | Current |
| Ambion Inc. | Research Scientist | Current |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
